Pacira BioSciences' Inventory rose 4095.56% to $157.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $157.7 million, marking a year-over-year increase of 4095.56%. This contributed to the annual value of $125.3 million for FY2024, which is 2005.6% up from last year.
Per Pacira BioSciences' latest filing, its Inventory stood at $157.7 million for Q3 2025, which was up 4095.56% from $148.2 million recorded in Q2 2025.
In the past 5 years, Pacira BioSciences' Inventory registered a high of $157.7 million during Q3 2025, and its lowest value of $64.6 million during Q1 2021.
For the 5-year period, Pacira BioSciences' Inventory averaged around $102.9 million, with its median value being $98.6 million (2021).
In the last 5 years, Pacira BioSciences' Inventory skyrocketed by 6045.26% in 2022 and then plummeted by 1030.75% in 2023.
Quarter analysis of 5 years shows Pacira BioSciences' Inventory stood at $98.6 million in 2021, then dropped by 2.52% to $96.1 million in 2022, then rose by 8.63% to $104.4 million in 2023, then grew by 20.06% to $125.3 million in 2024, then rose by 25.86% to $157.7 million in 2025.
Its last three reported values are $157.7 million in Q3 2025, $148.2 million for Q2 2025, and $133.8 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value